Key points are not available for this paper at this time.
In silico and in vitro studies reveal that astilbin inhibits AG and is superior to acarbose, validating its promise as an AG inhibitor. Overall, astilbin was the most bioactive component of BC for antidiabetic action.
Eawsakul et al. (Mon,) studied this question.